A study on the role of far infra red therapy on arteriovenous fistula maturation and survival in hemodialysis patients.

A prospective randomized open labelled study on the role of far infrared therapy on AVF maturation, survival in hemodialysis patients - NA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069406

Enrollment

128

Registered

2024-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: FAR INFRARED: patients in intervention arm receive far infra red therapy thrice per week ,each session lasting for 40 minutes for 6 weeks. Control Intervention1: Isometric exercise: pa

Eligibility

Inclusion criteria

Inclusion criteria: CKD Stage 5 Planned for Primary AVF Creation

Exclusion criteria

Exclusion criteria: Complex vascular access procedure. Repeat AVF Creation. AVF site infection. Not able to give consent

Design outcomes

Primary

Measure	Time frame
1.To study the role of FIR therapy on AVF maturation 2.Role of FIR therapy on AVF survivalTimepoint: 2 years	—

Secondary

Measure	Time frame
Correlation between imaging parameters & AVF survivalTimepoint: 2 years	—

Countries

India

Contacts

Public ContactDan elizabeth sunny

Government medical college ,Kozhikode

nephcal@gmail.com8547434754

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026